Higher Risk of Blood Clots From COVID-19 Than Vaccines 19/04/2021 Chandre Prince The risk of developing a rare brain blood clot is eight to ten times higher in people infected with COVID-19 than those who get a vaccine, a new study has found. The study by Oxford University last week reported that the risk of the rare blood clotting known as cerebral venous thrombosis (CVT) following COVID-19 […] Continue reading -> People Might Need a 3rd COVID-19 Vaccine Booster, says Pfizer CEO 19/04/2021 Chandre Prince People are “likely” to need a third dose of the coronavirus vaccine within 12 months of getting the first two doses of the Pfizer-BioNTech vaccine, Pfizer CEO Albert Bourla said during a recent interview. The third booster jab could be necessary “somewhere between six and 12 months” after the second one and possibly even annually, […] Continue reading -> Global Shortage of Innovative Antibiotics Fuels Spread of Drug-Resistance, Says New Report 16/04/2021 Raisa Santos Despite growing awareness of the urgent threat of antibiotic resistance, the world is still failing to develop needed antibacterial treats, according to a new report by the World Health Organization (WHO). Of the 43 antibiotics and 27 non-traditional antibacterial agents in the current clinical antibacterial pipeline, none is sufficient to tackle the challenge of increasing […] Continue reading -> Unitaid Commemorates World Chagas Day With New Initiative To Prevent Mother-To-Child Transmission 15/04/2021 Editorial team In commemoration of World Chagas Disease Day, Unitaid and the Brazilian Ministry of Health launched a $19 million initiative to expand access to affordable diagnostics and treatments for women and newborns in four Latin American countries where Chagas disease is endemic – Brazil, Bolivia, Colombia, and Paraguay. Transmitted by the blood-sucking triatomine bug called Trypanosoma […] Continue reading -> Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> UK COVID-19 Variant Not Linked to Severe Disease or Reinfection – New Lancet Study 14/04/2021 Editorial team Two studies published by The Lancet Infectious Disease and The Lancet Public Health report that the United Kingdom’s dominant strain of the virus is not linked to more severe disease or death, and that there was no apparent increase in reinfection rate from the variant. The variant of SARS-CoV-2 2, B.1.1.7, emerged as the dominant […] Continue reading -> WHO’s Unprecedented Appeal: Suspend Sale & Slaughter Of Live Wild Mammals In Food Markets To Head Off New Virus Risks 13/04/2021 Elaine Ruth Fletcher In an unusually bold step for the cautious global health agency, the World Health Organization has called upon countries to suspend the sale of captured live wild mammals in food markets as an emergency measure. The appeal follows on the publication of a report by a WHO-convened international team examining the origins of the SARS-CoV2 […] Continue reading -> United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> EMA Reviews Link Between Blood Clots and Johnson & Johnson Vaccine 09/04/2021 Kerry Cullinan The European Medicines Agency is reviewing the cases of four people who developed blood clots after receiving Johnson & Johnson’s (J&J) COVID-19 vaccine, the regulator announced on Friday. “Four serious cases of unusual blood clots with low blood platelets have been reported post-vaccination with COVID-19 Vaccine Janssen. One case occurred in a clinical trial and […] Continue reading -> Ivermectin For COVID: Insignificant Results In Treatment Of Mild Cases – WHO Recommends Use Only In Clinical Trials 02/04/2021 Editorial team A recent trial of ivermectin, a mainstay treatment for the parasitic disease onchocerciasis for the past three decades, has failed to show significant impacts against COVID-19, a new study, published in JAMA, reports. The study by a group of researchers in Cali, Colombia found that the use of the antiparitic drug, typically used to treat onchocersiasis […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
People Might Need a 3rd COVID-19 Vaccine Booster, says Pfizer CEO 19/04/2021 Chandre Prince People are “likely” to need a third dose of the coronavirus vaccine within 12 months of getting the first two doses of the Pfizer-BioNTech vaccine, Pfizer CEO Albert Bourla said during a recent interview. The third booster jab could be necessary “somewhere between six and 12 months” after the second one and possibly even annually, […] Continue reading -> Global Shortage of Innovative Antibiotics Fuels Spread of Drug-Resistance, Says New Report 16/04/2021 Raisa Santos Despite growing awareness of the urgent threat of antibiotic resistance, the world is still failing to develop needed antibacterial treats, according to a new report by the World Health Organization (WHO). Of the 43 antibiotics and 27 non-traditional antibacterial agents in the current clinical antibacterial pipeline, none is sufficient to tackle the challenge of increasing […] Continue reading -> Unitaid Commemorates World Chagas Day With New Initiative To Prevent Mother-To-Child Transmission 15/04/2021 Editorial team In commemoration of World Chagas Disease Day, Unitaid and the Brazilian Ministry of Health launched a $19 million initiative to expand access to affordable diagnostics and treatments for women and newborns in four Latin American countries where Chagas disease is endemic – Brazil, Bolivia, Colombia, and Paraguay. Transmitted by the blood-sucking triatomine bug called Trypanosoma […] Continue reading -> Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> UK COVID-19 Variant Not Linked to Severe Disease or Reinfection – New Lancet Study 14/04/2021 Editorial team Two studies published by The Lancet Infectious Disease and The Lancet Public Health report that the United Kingdom’s dominant strain of the virus is not linked to more severe disease or death, and that there was no apparent increase in reinfection rate from the variant. The variant of SARS-CoV-2 2, B.1.1.7, emerged as the dominant […] Continue reading -> WHO’s Unprecedented Appeal: Suspend Sale & Slaughter Of Live Wild Mammals In Food Markets To Head Off New Virus Risks 13/04/2021 Elaine Ruth Fletcher In an unusually bold step for the cautious global health agency, the World Health Organization has called upon countries to suspend the sale of captured live wild mammals in food markets as an emergency measure. The appeal follows on the publication of a report by a WHO-convened international team examining the origins of the SARS-CoV2 […] Continue reading -> United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> EMA Reviews Link Between Blood Clots and Johnson & Johnson Vaccine 09/04/2021 Kerry Cullinan The European Medicines Agency is reviewing the cases of four people who developed blood clots after receiving Johnson & Johnson’s (J&J) COVID-19 vaccine, the regulator announced on Friday. “Four serious cases of unusual blood clots with low blood platelets have been reported post-vaccination with COVID-19 Vaccine Janssen. One case occurred in a clinical trial and […] Continue reading -> Ivermectin For COVID: Insignificant Results In Treatment Of Mild Cases – WHO Recommends Use Only In Clinical Trials 02/04/2021 Editorial team A recent trial of ivermectin, a mainstay treatment for the parasitic disease onchocerciasis for the past three decades, has failed to show significant impacts against COVID-19, a new study, published in JAMA, reports. The study by a group of researchers in Cali, Colombia found that the use of the antiparitic drug, typically used to treat onchocersiasis […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global Shortage of Innovative Antibiotics Fuels Spread of Drug-Resistance, Says New Report 16/04/2021 Raisa Santos Despite growing awareness of the urgent threat of antibiotic resistance, the world is still failing to develop needed antibacterial treats, according to a new report by the World Health Organization (WHO). Of the 43 antibiotics and 27 non-traditional antibacterial agents in the current clinical antibacterial pipeline, none is sufficient to tackle the challenge of increasing […] Continue reading -> Unitaid Commemorates World Chagas Day With New Initiative To Prevent Mother-To-Child Transmission 15/04/2021 Editorial team In commemoration of World Chagas Disease Day, Unitaid and the Brazilian Ministry of Health launched a $19 million initiative to expand access to affordable diagnostics and treatments for women and newborns in four Latin American countries where Chagas disease is endemic – Brazil, Bolivia, Colombia, and Paraguay. Transmitted by the blood-sucking triatomine bug called Trypanosoma […] Continue reading -> Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> UK COVID-19 Variant Not Linked to Severe Disease or Reinfection – New Lancet Study 14/04/2021 Editorial team Two studies published by The Lancet Infectious Disease and The Lancet Public Health report that the United Kingdom’s dominant strain of the virus is not linked to more severe disease or death, and that there was no apparent increase in reinfection rate from the variant. The variant of SARS-CoV-2 2, B.1.1.7, emerged as the dominant […] Continue reading -> WHO’s Unprecedented Appeal: Suspend Sale & Slaughter Of Live Wild Mammals In Food Markets To Head Off New Virus Risks 13/04/2021 Elaine Ruth Fletcher In an unusually bold step for the cautious global health agency, the World Health Organization has called upon countries to suspend the sale of captured live wild mammals in food markets as an emergency measure. The appeal follows on the publication of a report by a WHO-convened international team examining the origins of the SARS-CoV2 […] Continue reading -> United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> EMA Reviews Link Between Blood Clots and Johnson & Johnson Vaccine 09/04/2021 Kerry Cullinan The European Medicines Agency is reviewing the cases of four people who developed blood clots after receiving Johnson & Johnson’s (J&J) COVID-19 vaccine, the regulator announced on Friday. “Four serious cases of unusual blood clots with low blood platelets have been reported post-vaccination with COVID-19 Vaccine Janssen. One case occurred in a clinical trial and […] Continue reading -> Ivermectin For COVID: Insignificant Results In Treatment Of Mild Cases – WHO Recommends Use Only In Clinical Trials 02/04/2021 Editorial team A recent trial of ivermectin, a mainstay treatment for the parasitic disease onchocerciasis for the past three decades, has failed to show significant impacts against COVID-19, a new study, published in JAMA, reports. The study by a group of researchers in Cali, Colombia found that the use of the antiparitic drug, typically used to treat onchocersiasis […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Unitaid Commemorates World Chagas Day With New Initiative To Prevent Mother-To-Child Transmission 15/04/2021 Editorial team In commemoration of World Chagas Disease Day, Unitaid and the Brazilian Ministry of Health launched a $19 million initiative to expand access to affordable diagnostics and treatments for women and newborns in four Latin American countries where Chagas disease is endemic – Brazil, Bolivia, Colombia, and Paraguay. Transmitted by the blood-sucking triatomine bug called Trypanosoma […] Continue reading -> Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> UK COVID-19 Variant Not Linked to Severe Disease or Reinfection – New Lancet Study 14/04/2021 Editorial team Two studies published by The Lancet Infectious Disease and The Lancet Public Health report that the United Kingdom’s dominant strain of the virus is not linked to more severe disease or death, and that there was no apparent increase in reinfection rate from the variant. The variant of SARS-CoV-2 2, B.1.1.7, emerged as the dominant […] Continue reading -> WHO’s Unprecedented Appeal: Suspend Sale & Slaughter Of Live Wild Mammals In Food Markets To Head Off New Virus Risks 13/04/2021 Elaine Ruth Fletcher In an unusually bold step for the cautious global health agency, the World Health Organization has called upon countries to suspend the sale of captured live wild mammals in food markets as an emergency measure. The appeal follows on the publication of a report by a WHO-convened international team examining the origins of the SARS-CoV2 […] Continue reading -> United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> EMA Reviews Link Between Blood Clots and Johnson & Johnson Vaccine 09/04/2021 Kerry Cullinan The European Medicines Agency is reviewing the cases of four people who developed blood clots after receiving Johnson & Johnson’s (J&J) COVID-19 vaccine, the regulator announced on Friday. “Four serious cases of unusual blood clots with low blood platelets have been reported post-vaccination with COVID-19 Vaccine Janssen. One case occurred in a clinical trial and […] Continue reading -> Ivermectin For COVID: Insignificant Results In Treatment Of Mild Cases – WHO Recommends Use Only In Clinical Trials 02/04/2021 Editorial team A recent trial of ivermectin, a mainstay treatment for the parasitic disease onchocerciasis for the past three decades, has failed to show significant impacts against COVID-19, a new study, published in JAMA, reports. The study by a group of researchers in Cali, Colombia found that the use of the antiparitic drug, typically used to treat onchocersiasis […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> UK COVID-19 Variant Not Linked to Severe Disease or Reinfection – New Lancet Study 14/04/2021 Editorial team Two studies published by The Lancet Infectious Disease and The Lancet Public Health report that the United Kingdom’s dominant strain of the virus is not linked to more severe disease or death, and that there was no apparent increase in reinfection rate from the variant. The variant of SARS-CoV-2 2, B.1.1.7, emerged as the dominant […] Continue reading -> WHO’s Unprecedented Appeal: Suspend Sale & Slaughter Of Live Wild Mammals In Food Markets To Head Off New Virus Risks 13/04/2021 Elaine Ruth Fletcher In an unusually bold step for the cautious global health agency, the World Health Organization has called upon countries to suspend the sale of captured live wild mammals in food markets as an emergency measure. The appeal follows on the publication of a report by a WHO-convened international team examining the origins of the SARS-CoV2 […] Continue reading -> United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> EMA Reviews Link Between Blood Clots and Johnson & Johnson Vaccine 09/04/2021 Kerry Cullinan The European Medicines Agency is reviewing the cases of four people who developed blood clots after receiving Johnson & Johnson’s (J&J) COVID-19 vaccine, the regulator announced on Friday. “Four serious cases of unusual blood clots with low blood platelets have been reported post-vaccination with COVID-19 Vaccine Janssen. One case occurred in a clinical trial and […] Continue reading -> Ivermectin For COVID: Insignificant Results In Treatment Of Mild Cases – WHO Recommends Use Only In Clinical Trials 02/04/2021 Editorial team A recent trial of ivermectin, a mainstay treatment for the parasitic disease onchocerciasis for the past three decades, has failed to show significant impacts against COVID-19, a new study, published in JAMA, reports. The study by a group of researchers in Cali, Colombia found that the use of the antiparitic drug, typically used to treat onchocersiasis […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
UK COVID-19 Variant Not Linked to Severe Disease or Reinfection – New Lancet Study 14/04/2021 Editorial team Two studies published by The Lancet Infectious Disease and The Lancet Public Health report that the United Kingdom’s dominant strain of the virus is not linked to more severe disease or death, and that there was no apparent increase in reinfection rate from the variant. The variant of SARS-CoV-2 2, B.1.1.7, emerged as the dominant […] Continue reading -> WHO’s Unprecedented Appeal: Suspend Sale & Slaughter Of Live Wild Mammals In Food Markets To Head Off New Virus Risks 13/04/2021 Elaine Ruth Fletcher In an unusually bold step for the cautious global health agency, the World Health Organization has called upon countries to suspend the sale of captured live wild mammals in food markets as an emergency measure. The appeal follows on the publication of a report by a WHO-convened international team examining the origins of the SARS-CoV2 […] Continue reading -> United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> EMA Reviews Link Between Blood Clots and Johnson & Johnson Vaccine 09/04/2021 Kerry Cullinan The European Medicines Agency is reviewing the cases of four people who developed blood clots after receiving Johnson & Johnson’s (J&J) COVID-19 vaccine, the regulator announced on Friday. “Four serious cases of unusual blood clots with low blood platelets have been reported post-vaccination with COVID-19 Vaccine Janssen. One case occurred in a clinical trial and […] Continue reading -> Ivermectin For COVID: Insignificant Results In Treatment Of Mild Cases – WHO Recommends Use Only In Clinical Trials 02/04/2021 Editorial team A recent trial of ivermectin, a mainstay treatment for the parasitic disease onchocerciasis for the past three decades, has failed to show significant impacts against COVID-19, a new study, published in JAMA, reports. The study by a group of researchers in Cali, Colombia found that the use of the antiparitic drug, typically used to treat onchocersiasis […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO’s Unprecedented Appeal: Suspend Sale & Slaughter Of Live Wild Mammals In Food Markets To Head Off New Virus Risks 13/04/2021 Elaine Ruth Fletcher In an unusually bold step for the cautious global health agency, the World Health Organization has called upon countries to suspend the sale of captured live wild mammals in food markets as an emergency measure. The appeal follows on the publication of a report by a WHO-convened international team examining the origins of the SARS-CoV2 […] Continue reading -> United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> EMA Reviews Link Between Blood Clots and Johnson & Johnson Vaccine 09/04/2021 Kerry Cullinan The European Medicines Agency is reviewing the cases of four people who developed blood clots after receiving Johnson & Johnson’s (J&J) COVID-19 vaccine, the regulator announced on Friday. “Four serious cases of unusual blood clots with low blood platelets have been reported post-vaccination with COVID-19 Vaccine Janssen. One case occurred in a clinical trial and […] Continue reading -> Ivermectin For COVID: Insignificant Results In Treatment Of Mild Cases – WHO Recommends Use Only In Clinical Trials 02/04/2021 Editorial team A recent trial of ivermectin, a mainstay treatment for the parasitic disease onchocerciasis for the past three decades, has failed to show significant impacts against COVID-19, a new study, published in JAMA, reports. The study by a group of researchers in Cali, Colombia found that the use of the antiparitic drug, typically used to treat onchocersiasis […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> EMA Reviews Link Between Blood Clots and Johnson & Johnson Vaccine 09/04/2021 Kerry Cullinan The European Medicines Agency is reviewing the cases of four people who developed blood clots after receiving Johnson & Johnson’s (J&J) COVID-19 vaccine, the regulator announced on Friday. “Four serious cases of unusual blood clots with low blood platelets have been reported post-vaccination with COVID-19 Vaccine Janssen. One case occurred in a clinical trial and […] Continue reading -> Ivermectin For COVID: Insignificant Results In Treatment Of Mild Cases – WHO Recommends Use Only In Clinical Trials 02/04/2021 Editorial team A recent trial of ivermectin, a mainstay treatment for the parasitic disease onchocerciasis for the past three decades, has failed to show significant impacts against COVID-19, a new study, published in JAMA, reports. The study by a group of researchers in Cali, Colombia found that the use of the antiparitic drug, typically used to treat onchocersiasis […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
EMA Reviews Link Between Blood Clots and Johnson & Johnson Vaccine 09/04/2021 Kerry Cullinan The European Medicines Agency is reviewing the cases of four people who developed blood clots after receiving Johnson & Johnson’s (J&J) COVID-19 vaccine, the regulator announced on Friday. “Four serious cases of unusual blood clots with low blood platelets have been reported post-vaccination with COVID-19 Vaccine Janssen. One case occurred in a clinical trial and […] Continue reading -> Ivermectin For COVID: Insignificant Results In Treatment Of Mild Cases – WHO Recommends Use Only In Clinical Trials 02/04/2021 Editorial team A recent trial of ivermectin, a mainstay treatment for the parasitic disease onchocerciasis for the past three decades, has failed to show significant impacts against COVID-19, a new study, published in JAMA, reports. The study by a group of researchers in Cali, Colombia found that the use of the antiparitic drug, typically used to treat onchocersiasis […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Ivermectin For COVID: Insignificant Results In Treatment Of Mild Cases – WHO Recommends Use Only In Clinical Trials 02/04/2021 Editorial team A recent trial of ivermectin, a mainstay treatment for the parasitic disease onchocerciasis for the past three decades, has failed to show significant impacts against COVID-19, a new study, published in JAMA, reports. The study by a group of researchers in Cali, Colombia found that the use of the antiparitic drug, typically used to treat onchocersiasis […] Continue reading -> Posts navigation Older postsNewer posts